U.S. flag

An official website of the United States government

Program Releases

The Centers for Medicare & Medicaid Services (CMS) issues program releases to states and drug manufacturers participating in the Medicaid Drug Rebate Program. To find prior releases by topic, please use the "Keyword Search" function below.

To further refine your search, we have also posted a Division of Pharmacy Releases Index, which is a compilation of all the State and Manufacturer Releases topics from 1991 to Present. Please download a copy for your reference.

If you have any questions regarding the states and/or drug manufacturer releases, please email MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS).  The statements included on this web page are intended to provide information on Medicaid Drug Rebate Program Releases and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), or regulations.

Page Last Updated on July 3, 2024

Showing 51 to 60 of 332 results

State Release 170

Date:
Type: State Release
Keywords: Orphan Drugs
Links: State Release 170: Collection of Medicaid Rebates for Certain Outpatient Orphan Drugs Dispensed by Certain 340B Entities ( PDF, 141.47 KB )
SHARE THIS PROGRAM RELEASE

Manufacturer Release 092

Date:
Type: Manufacturer Release
Keywords: Biosimilars, biologic products, BLA, Preferred Drug Lists, Biosimilars and Preferred Drug Lists, MCO utilization data, MCO utilization records, zero and amount reimbursed, BPD, BPD and zero reimbursement amount, postmark dates
Links: Manufacturer Release 092: Biosimilars; 0 as a Valid Value for Medicaid Amount Reimbursed/Total Amount Reimbursed Fields on MCO Utilization Records; BPD Program and Valid MCO Utilization Values; Postmark Dates when Using Secure Websites ( PDF, 156.17 KB )
SHARE THIS PROGRAM RELEASE

State Release 169

Date:
Type: State Release
Keywords: Biosimilars, biologic products, BLA, Preferred Drug Lists, Biosimilars and Preferred Drug Lists, MCO utilization data, MCO utilization records, zero and amount reimbursed, BPD, BPD and zero reimbursement amount, postmark dates
Links: State Release 169: Biosimilars and MDRP; Zeros as a Valid Value for Medicaid Amount Reimbursed & Total Amount Reimbursed Fields on MCO Utilization Records; BPD Program and Zero Reimbursement Amount MCO Utilization Values ( PDF, 161.66 KB )
SHARE THIS PROGRAM RELEASE

Manufacturer Release 091

Date:
Type: Manufacturer Release
Keywords: Timely Reporting of AMP & BP Data, Correctly Reporting of Drug Categories, Terminated Manufacturers from MDR, Terminated Products from MDR, Product Termination for Late Reporting, 12 Quarter Rule for Revisions of AMP & BP, Inquires Reported to Resource Box for Branded Prescription Drugs
Links: Manufacturer Release 091: Timely Reporting of AMP/BP; Reporting a Drug Category; Rebate Obligations for Terminated Manufacturers and Products; Late Submissions of Product Termination Dates; 12 Quarter Rule ( PDF, 164.62 KB )
SHARE THIS PROGRAM RELEASE

State Release 168

Date:
Type: State Release
Keywords: Obligations for terminated manufacturers and terminated products, Late submissions of product termination dates
Links: State Release 168: Guidance on Rebate Obligations for Terminated Manufacturers and Products; Termination of a Manufacturer and Product from MDRP; Late Submission of Product Termination Dates; New Director of the Division of Pharmacy ( PDF, 103.12 KB )
SHARE THIS PROGRAM RELEASE

State Release 167

Date:
Type: State Release
Keywords: CMS-64 Reporting, Drug Rebate Reporting, Allocation Methodologies, FMAP for Drug Rebate
Links: State Release 167: Information for Quarterly Reporting of Rebates in MBES; CMS-64 Drug Rebate Reporting; Federal Matching Rates; Methods for Determining FMAP for Drug Rebate Amounts; Acceptable Allocation Methodologies ( PDF, 136.15 KB )
SHARE THIS PROGRAM RELEASE

Manufacturer Release 090

Date:
Type: Manufacturer Release
Keywords: Baseline Data, Buying a Drug, Sale of Authorized Generics, Branded Prescription Drug Fees
Links: Manufacturer Release 090: Reporting Baseline Data; Buying a Drug from another Manufacturer; Buying a Drug but Not Changing the NDC; Buying a Drug and Changing the NDC; Sale of Authorized Generic Drugs; 2012 State Utilization Data for BPD Fees ( PDF, 146.23 KB )
SHARE THIS PROGRAM RELEASE

Manufacturer Release 089

Date:
Type: Manufacturer Release
Keywords: 2012 State Utilization data for BPD fees, Using CMS form 304 (Rosi) and CMS form 304A (PQAS) format, Clarification of postmark dates of calculating interest
Links: Manufacturer Release 089: 2012 State Utilization Data for Branded Prescription Drug (BPD) Fees; Clarification of Postmark Dates for Purposes of Calculating Interest; DESI Code Correction; Retirement News ( PDF, 156.32 KB )
SHARE THIS PROGRAM RELEASE

State Release 166

Date:
Type: State Release
Keywords: 2012 State Utilization data for BPD fees, Clarification of postmark dates of calculating interest, Desi Code correction, Product deletion
Links: State Release 166: 2012 State Utilization Data for Branded Prescription Drug (BPD) Fees; Clarification of Postmark Dates for Purposes of Calculating Interest; DESI Code Correction; Retirement News ( PDF, 152.47 KB )
SHARE THIS PROGRAM RELEASE

Manufacturer Release 088

Date:
Type: Manufacturer Release
Keywords: Coverage of Barbiturates, Benzodiazepines, All Drugs Used for Smoking Cessation, 2014
Links: Manufacturer Release 088: Coverage of Barbiturates, Benzodiazepines, and all Drugs Used for Smoking Cessation Effective January 1, 2014; Medicaid Beneficiaries; Dual Eligible Beneficiaries; State Plan Amendments ( PDF, 135.49 KB )
SHARE THIS PROGRAM RELEASE
entries